Smad3 deficiency leads to aortic aneurysms and sudden death in Smad3 knockout mice.
Upstream TGF-β receptor signaling is activated, yet downstream TGF-β-activated transcription is impaired in Smad3-/- VSMCs
Improper TGF-β induced downstream gene activation in Smad3-/- VSMCs impairs ECM formation and weakens aortic structure
Mutations in the Smad3 gene cause aortic aneurysms and joint disorders. Since aneurysm growth is highly unpredictable in Smad3 patients, early diagnosis is of vital importance. Here we identify the molecular basis for this unpredictable and acute aneurysm growth using Smad3 knockout mice. Dysregulation of the downstream TGFβ signaling pathway due to absence of Smad3 weakens the extracellular matrix of vascular smooth muscle cells and changes the aortic composition, thereby leading to the attraction of immune cells. These findings provide a rationale for the variable clinical outcome in Smad3 patients and open up new intervention possibilities.